PortfoliosLab logoPortfoliosLab logo
QVCGA vs. SKYE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

QVCGA vs. SKYE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in QVC Group Inc (QVCGA) and Skye Bioscience, Inc (SKYE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


QVCGA

1D
0.00%
1M
0.00%
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*

SKYE

1D
0.68%
1M
-7.58%
6M
-34.63%
YTD
-12.81%
1Y
-83.20%
3Y*
-54.08%
5Y*
-55.74%
10Y*
-40.13%
ALL TIME*
-48.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

QVCGA vs. SKYE - Yearly Performance Comparison


2026 (YTD)
QVCGA
QVC Group Inc
0.00%
SKYE
Skye Bioscience, Inc
-21.10%

Fundamentals

Market Cap

QVCGA:

$2.69M

SKYE:

$22.97M

EPS

QVCGA:

-$301.98

SKYE:

-$1.45

Total Revenue (TTM)

QVCGA:

$9.23B

SKYE:

$0.00

Gross Profit (TTM)

QVCGA:

$2.89B

SKYE:

-$180.01K

EBITDA (TTM)

QVCGA:

$789.00M

SKYE:

$10.92M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

QVCGA vs. SKYE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QVCGA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


SKYE
SKYE Risk / Return Rank: 1010
Overall Rank
SKYE Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
SKYE Sortino Ratio Rank: 99
Sortino Ratio Rank
SKYE Omega Ratio Rank: 88
Omega Ratio Rank
SKYE Calmar Ratio Rank: 55
Calmar Ratio Rank
SKYE Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QVCGA vs. SKYE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for QVC Group Inc (QVCGA) and Skye Bioscience, Inc (SKYE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


QVCGASKYEDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.82

Calmar ratioReturn relative to maximum drawdown

-0.95

Martin ratioReturn relative to average drawdown

-1.17

QVCGA vs. SKYE - Sharpe Ratio Comparison


Loading charts...

Drawdowns

QVCGA vs. SKYE - Drawdown Comparison

The maximum QVCGA drawdown since its inception was 0.00%, smaller than the maximum SKYE drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for QVCGA and SKYE.


Loading charts...

Drawdown Indicators


QVCGASKYEDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-99.96%

+99.96%

Max Drawdown (1Y)

Largest decline over 1 year

-87.85%

Max Drawdown (3Y)

Largest decline over 3 years

-96.79%

Max Drawdown (5Y)

Largest decline over 5 years

-98.56%

Max Drawdown (10Y)

Largest decline over 10 years

-99.83%

Current Drawdown

Current decline from peak

0.00%

-99.95%

+99.95%

Average Drawdown

Average peak-to-trough decline

0.00%

-94.97%

+94.97%

Ulcer Index

Depth and duration of drawdowns from previous peaks

71.33%

Volatility

QVCGA vs. SKYE - Volatility Comparison


Loading charts...

Volatility by Period


QVCGASKYEDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.30%

Volatility (6M)

Calculated over the trailing 6-month period

54.45%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

104.19%

-104.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

130.62%

-130.62%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

136.40%

-136.40%

Dividends

QVCGA vs. SKYE - Dividend Comparison

Neither QVCGA nor SKYE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

QVCGA vs. SKYE - Financials Comparison

This section allows you to compare key financial metrics between QVC Group Inc and Skye Bioscience, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
2.68B
0
(QVCGA) Total Revenue
(SKYE) Total Revenue
Values in USD except per share items
Portfolio Optimizer

Find the right allocation for QVCGA and SKYE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer